PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
42.52K
Worse than FBIO's estimated revenue of 57.13M.
-8.50K
Better than FBIO's estimated ebitda of -57.13M.
-1.41
Better than FBIO's estimated eps of -3.51.
-41.31M
Better than FBIO's estimated net income of -72.88M.
-8.50K
Better than FBIO's estimated ebit of -57.13M.
1.58M
Better than FBIO's estimated sg&a expense of 76.58M.
Analyze DCF forecasts for the company and compare them with competitors.
1.14M
Worse than FBIO's revenue of 68.79M.
No Data
No DCF data available for this metric in the selected year.
-24.44M
Better than FBIO's ebitda of -142.25M.
-2136.36%
Worse than FBIO's ebitda margin of -206.79%.
-24.96M
Better than FBIO's ebit of -149.04M.
-2182.17%
Worse than FBIO's ebit margin of -216.66%.
524.00K
Better than FBIO's depreciation of 6.79M.
77.83M
Worse than FBIO's total cash of 305.74M.
6803.23%
Better than FBIO's cash as percentage of revenue of 444.45%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
5.54M
Better than FBIO's accounts payable of 47.43M.
483.83%
Worse than FBIO's payables as percentage of revenue of 68.95%.
-133.00K
Worse than FBIO's capital expenditure of -16.35M.
-11.63%
Worse than FBIO's capex as percentage of revenue of -23.76%.
4.99%
Better than FBIO's weighted average cost of capital (wacc) of 14.45%.
5.02%
Better than FBIO's cost of equity of 12.83%.
4.08%
Better than FBIO's cost of debt of 15.26%.
-0.23
Better than FBIO's beta of 1.86.
30.07M
Worse than FBIO's diluted shares outstanding of 20.78M.
1.57M
Better than FBIO's total debt of 75.96M.
49.31M
Better than FBIO's total equity of 37.62M.
50.89M
Worse than FBIO's total capital of 113.58M.
3.09%
Better than FBIO's debt weighting of 66.88%.
96.91%
Better than FBIO's equity weighting of 33.12%.
-24.77M
Better than FBIO's ebiat of -149.47M.
-23.19M
Better than FBIO's unlevered free cash flow of -135.91M.
2.00%
Equal to FBIO's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than FBIO's net debt of 18.70M.
71.33M
Better than FBIO's equity value of -619.84M.
2.37
Better than FBIO's equity value per share of -29.82.